Tumor infiltrating T lymphocyte, isolated and expanded from breast cancer patient expressed PD-1, were treated with LCN-siRNA PD-1 NPs, and their cytotoxic capability was tested in vitro against the MCF-7 cell line previously treated with LCN-siRNA PD-L1 NPs. The gene discussed is CD274; the disease is breast carcinoma.